LADENBURG THALM/SH SH began coverage on shares of Marker Therapeutics (NASDAQ:MRKR – Free Report) in a report published on Tuesday morning, Benzinga reports. The brokerage issued a buy rating and a $11.00 target price on the stock. Marker Therapeutics Price Performance NASDAQ MRKR opened at $4.11 on Tuesday. The business’s fifty day moving average price […]
Alliant Energy (NASDAQ:LNT – Free Report) had its price objective cut by LADENBURG THALM/SH SH from $48.50 to $48.00 in a report released on Monday, Benzinga reports. They currently have a neutral rating on the stock. Several other equities analysts have also recently weighed in on LNT. Bank of America cut their price objective on […]
LADENBURG THALM/SH SH lowered shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) from a buy rating to a neutral rating in a research report report published on Monday morning, Marketbeat Ratings reports. Other equities analysts also recently issued research reports about the company. HC Wainwright reaffirmed a buy rating and issued a $20.00 price objective […]
Equities researchers at LADENBURG THALM/SH SH began coverage on shares of Marker Therapeutics (NASDAQ:MRKR – Get Free Report) in a research note issued on Tuesday, Benzinga reports. The brokerage set a “buy” rating and a $11.00 price target on the stock. LADENBURG THALM/SH SH’s price objective points to a potential upside of 157.01% from the […]
Equities researchers at LADENBURG THALM/SH SH assumed coverage on shares of Marker Therapeutics (NASDAQ:MRKR – Get Free Report) in a note issued to investors on Tuesday, Benzinga reports. The brokerage set a “buy” rating and a $11.00 price target on the stock. LADENBURG THALM/SH SH’s price objective would indicate a potential upside of 157.01% from […]